Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC)

CUSIP: 359616109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
66,594,760
Total 13F shares
52,209,184
Share change
+11,868,434
Total reported value
$422,360,458
Put/Call ratio
5.5%
Price per share
$8.09
Number of holders
104
Value change
+$98,764,326
Number of buys
61
Number of sells
42

Security key

359616109

Report period

Q3 2022

Institutions

104

Top holders

10

Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
9.2%
6,127,231
$30,023,000 30 Jun 2022
13F
TRV GP III, LLC
13F
Company
5.9%
3,962,202
$19,415,000 30 Jun 2022
13F
RTW INVESTMENTS, LP
13F
Company
5.9%
3,961,194
$19,410,000 30 Jun 2022
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
5%
3,355,624
$16,443,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
4%
2,654,378
$13,005,000 30 Jun 2022
13F
COWEN AND COMPANY, LLC
13F
Company
3.6%
2,385,885
$11,691,000 30 Jun 2022
13F
TRV GP IV, LLC
13F
Company
3.5%
2,343,154
$11,481,000 30 Jun 2022
13F
Point72 Asset Management, L.P.
13F
Company
3%
1,988,800
$9,745,000 30 Jun 2022
13F
Logos Global Management LP
13F
Company
2.9%
1,950,000
$9,555,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
2.3%
1,529,662
$7,495,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
1.8%
1,178,763
$5,776,000 30 Jun 2022
13F
Deep Track Capital, LP
13F
Company
1.5%
1,000,000
$4,900,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
0.97%
648,666
$3,178,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.85%
566,513
$2,775,000 30 Jun 2022
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.62%
410,714
$2,012,000 30 Jun 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.6%
401,142
$1,965,000 30 Jun 2022
13F
Rock Springs Capital Management LP
13F
Company
0.58%
384,590
$1,884,000 30 Jun 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.54%
362,104
$1,773,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.46%
308,207
$1,510,000 30 Jun 2022
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.44%
294,118
$1,441,000 30 Jun 2022
13F
BESSEMER GROUP INC
13F
Company
0.43%
285,714
$1,400,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.43%
284,305
$1,393,000 30 Jun 2022
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.41%
270,000
$1,323,000 30 Jun 2022
13F
Parkman Healthcare Partners LLC
13F
Company
0.39%
262,689
$1,287,000 30 Jun 2022
13F
Alphabet Inc.
13F
Company
0.38%
255,452
$1,252,000 30 Jun 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.38%
253,054
$1,240,000 30 Jun 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.32%
214,763
$1,052,000 30 Jun 2022
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.3%
200,000
$980,000 30 Jun 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.3%
198,115
$971,000 30 Jun 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.21%
139,482
$683,000 30 Jun 2022
13F
FIDUCIARY TRUST CO
13F
Company
0.2%
132,472
$649,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.17%
111,300
$545,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.16%
104,420
$512,000 30 Jun 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.16%
103,667
$508,000 30 Jun 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.13%
85,919
$422,000 30 Jun 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.12%
81,197
$398,000 30 Jun 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.1%
68,000
$333,000 30 Jun 2022
13F
Swiss National Bank
13F
Company
0.09%
62,400
$306,000 30 Jun 2022
13F
Tekla Capital Management LLC
13F
Company
0.09%
58,537
$287,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.08%
56,047
$275,000 30 Jun 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
47,527
$233,000 30 Jun 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.06%
37,930
$186,000 30 Jun 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.06%
36,701
$180,000 30 Jun 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.05%
33,500
$164,000 30 Jun 2022
13F
Qube Research & Technologies Ltd
13F
Company
0.05%
31,813
$156,000 30 Jun 2022
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.05%
31,438
$154,000 30 Jun 2022
13F
Squarepoint Ops LLC
13F
Company
0.05%
30,936
$152,000 30 Jun 2022
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.05%
30,600
$150,000 30 Jun 2022
13F
COUNTRY TRUST BANK
13F
Company
0.05%
30,186
$148,000 30 Jun 2022
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.05%
30,012
$147,000 30 Jun 2022
13F

Institutional Holders of Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) as of Q3 2022

As of 30 Sep 2022, Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,209,184 shares. The largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, TRV GP III, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., COWEN AND COMPANY, LLC, TRV GP IV, LLC, VANGUARD GROUP INC, and Logos Global Management LP. This page lists 104 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
97
Q3 2022 holders
104
Holder diff
7
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .